ARTICLE | Company News
Chiron receives FDA letter
July 13, 2001 7:00 AM UTC
CHIR said it received a complete review letter from the FDA regarding its BLA for its nucleic acid test (NAT) to screen blood for hepatitis C virus and HIV-1. The company would not comment on the cont...